Search results

We partner with international pharmaceutical companies to act as Swiss marketing authorization holder and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced and provide in-depth expertise of commercial operations in domains like oncology and rare diseases. SFL Pharma ha

Redbiotec was founded in 2006 as an ETH spin-off. Having sold its CMV vaccine business to Pfizer in 2015, Redbiotec has since developed potent HSV-2 immunotherapies, and a platform technology of engineered bacteria - BRISPR® - to deliver therapeutic cargos of various nature for the treatment of cancer and ge

REGENHU’s mission is to enable our users to achieve their medical technology goals and ambitions using our 3D bioprinter systems and our ongoing supporting expertise, including the fabrication of personalized medicines, cellular 3D models and human tissues and organs.

ReseaChem was founded in 1996 as a spin-off company of the University of Applied Sciences Berne located in Burgdorf, Switzerland. ReseaChem offers a broad range of services in custom synthesis, analytics as well as isolation of chemical products.

Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents.

Neurix is a Geneva-based preclinical CRO offering in vitro drug testing services. We are active in neuroscience and SARS-CoV-2 areas by the use of 3D organoid technologies. We aim at mimicking closely the human physiology, thus de-risk drug development with relevant in vitro models.

A private pharmaceutical company re-purposing an existing approved drug for a new indication. N-003 (ambrisentan) may be the first therapy for portal hypertension and its complications in patients with liver cirrhosis.

Nestlé is the world’s largest food and beverage company. We have more than 2000 brands ranging from global icons to local favourites, and we are present in 189 countries around the world.

LASCCO SA is a biomedical-technology development private company based at the Biopole of Lausanne, Switzerland.

Our creations inspire emotions, touch millions of lives. By becoming a purpose-led company, we go further in making our world a happier, healthier place. Together, we have the potential to increase our positive impact on the world by innovating sustainable solutions while showing our love for nature.

Ferring is committed to helping people around the world build healthy families and live better lives. Headquartered in canton of Vaud, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.

We are a service provider for pharma, biotech and academia specialized in analyzing protein-protein interactions using LC-MS/MS. Especially identifying targets and off-targets of drugs and identify new drug targets on living cell (LRC-TriCEPS).

DXC RT is a biotechnology company offering plant-derived products with valuable high-quality compounds for cosmetic, nutritional, and pharmaceutical industries. We apply a green process to produce clean, safe, high quality plant materials in an innovative way.

DAMIAN Pharma is a privately-held pharmaceutical company incorporated in Switzerland, with access to one of the largest networks of life science companies and business experts. Led by an experienced team of executives, DAMIAN focuses on creating value that benefits patients and shareholders.

CARBOGEN AMCIS is a leading provider of drug development and commercialization services to pharmaceutical and biopharmaceutical companies across all development stages.

Biotech Concepts Ltd. is focused on biotech processes and process development consultancy. The development of anti-infective substances for novel drug targets and targeting approaches, thereby contribute to solve the unmet medical needs in combating (recurring) infectious diseases is a second area.

BMA is a Swiss biotech founded by immunologists, developing and commercializing antibodies and ELISA kits for in-vitro research. It offers monoclonal and polyclonal antibodies made with serum-free media, supporting sustainability, reproducibility, and applications from cancer to infectious diseases.

The BCC is a unique facility based in Fribourg, Switzerland, that provides services and research collaborations for the development of biopharmaceutical bioprocesses, as well as theoretical and practical training courses at all levels to the biopharmaceutical industry;

Since 1982, BIOREBA has been an independent biotech company offering diagnostic tests such as ELISA or PCR for serological and molecular analysis of plant pathogens. Our high quality products are available worldwide. BIOREBA is ISO 9001 and ISO/IEC 17025 certified for plant pathogen analysis.

Development, production and commercialization of biological plant protection products.

In its work to further the AO Foundation's mission, AO Research Institute Davos's purpose is to advance orthopedic patient care through innovative research and development.

AGINKO Research is a premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support drug and medical device established companies as well as start-ups and academia.

AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation oral integrin modulators of allosteric mode of action protecting the integrity of tissues afflicted by autoimmunity.  The next target milestone is clinical therapeutic proof-of-concept.

4D Lifetec has developed an easy-to-use blood test consisting of a patented RO platform technology and a proprietary immuno-biomarker to detect DNA degradation early. A protected AI enables high-throughput analysis. The assay succesfully passed first clinical documention for oncology and longevity.

ABAC‘s objective are low intervention, low waste and bioavailability enhancing process inventions for providing consumers with beneficial active food ingredients.

Abionic has developed a revolutionary nanofluidic technology providing professionals a unique and ultra-fast point of care diagnostic tool allowing immediate access to results for a large panel of blood tests. Abionic has developed the fastest sepsis test to identify people at risk to develop sepsis.